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SUMMARY 
Objective: This study aims to determine the incidence, 
age, gender, orofacial sites and histological pattern of 
paediatric orofacial tumours in a Nigerian population. 
The yearly findings will be analysed to identify the 
interval for increase in the incidence of paediatric oro-
facial tumours. 
Patients and Methods: A 21-year (1990 to 2010) ret-
rospective analysis of paediatric orofacial tumours in 
children younger than 16 years was carried out in the 
Department of Oral Pathology/Oral Medicine, Univer-
sity of Benin Teaching Hospital, Benin City, Nigeria.  
Results: Of the 1013 diagnosed lesions within the 
study period, there were 137 (13.5%) paediatric orofa-
cial tumours, among which 71 (51.8%) cases occurred 
within the last 6 years (2005 to 2010). There was male 
predilection for the lesions (78 males to 59 females, 
ratio = 1.3:1). The mean age was 9 + 4.3 years, with 
peak age group of 11 to 15 years (n=60, 43.8%). The 
mandible (n=44, 32.1%), followed by the maxilla 
(n=42, 30.7%) and orofacial soft tissue (n=19, 13.9%) 
were the most common sites. The benign tumours 
(n=72, 52.6%) were slightly more than the malignant 
tumours (n=65, 47.4%). There were more malignant 
tumours (n=23, 16.8%) than benign tumours (n=20, 
14.6%) within the last 3 years (2008 to 2010) under 
review. Burkitt’s lymphoma (n=38, 27.7%) was the 
commonest malignant lesion. 
Conclusion: This study showed a recent increase in the 
incidence of paediatric orofacial tumours, particularly 
due to a higher incidence of Burkitt’s lymphoma.  
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INTRODUCTION 
Previous reports show that the incidence of paediatric 
orofacial tumours was relatively low, (9.1% to 10.7%). 
It consists predominantly of benign tumours (91% to 
97.1%), while malignant tumours constitute 2.9% to 
9%.1-3 However, recent reports from Nigerian studies 
show an increasing incidence of paediatric orofacial 
tumours (24% to 28%) 4,5 in our environment.  
 
A higher incidence of malignant orofacial tumours 
among paediatric patients is also reported among Nige-
rians by Ajayi et al4 in Lagos (13.3%) and Omoregie et 
al 6 in Benin (22.5%). Furthermore, Aregbesola et al5 
reported a higher incidence of malignant paediatric 
orofacial tumour (51%) than the benign tumours 
(49%).  
 
Malignant lesions are a cause of oral health concern in 
children even with the current effort to control com-
municable diseases in the third world countries.7 In our 
environment they rank fourth as a cause of mortality.8 
Orofacial malignancies are of great concern because of 
the associated high mortality due to late presentation 
for treatment,9,10 a low 5-year survival rate  (55%),11 
poverty, lack of awareness and local beliefs.12 Moreo-
ver, paediatric orofacial tumours whether benign or 
malignant may be associated with facial disfigurement 
with associated psychosocial problems.13-15  
 
So far, no study in our environment has evaluated the 
incidence of paediatric tumours with a view to deter-
mine if there is an increase incidence of these lesions 
over a given period. Also, the specific clinico-
demographic factors and histological pattern of the 
lesions within a surge period is yet to be determined. 
This study aims to determine the incidence, age, gen-
der, orofacial sites and histological pattern of paediatric 
orofacial tumours in a Nigerian population. It also aims 
to analyse the yearly findings in order to establish the 
incidence of the lesions during the study period.  
 
METHODS 
Ethical approval was obtained from the Hospital Ethi-
cal Committee to carry out a 21-year (1990 to 2010) 
retrospective analysis of all paediatric orofacial tu-
mours seen in children younger than 16 years, in the 
Department of Oral Pathology/Oral Medicine, Univer-
sity of Benin Teaching Hospital, Benin City, Nigeria. 
 
 




This hospital serves as a major referral health centre in 
the south-south region of Nigeria and receives speci-
mens from other hospitals in the city and parts of the 
South-East and South-West of Nigeria.   
 
The incidence, age, gender, sites and histopathological 
patterns of paediatric orofacial tumours were obtained 
from the records of cases and histopathology registers. 
The histopathology slides of paediatric patients seen 
within the 21-year study period were reviewed. The 
data collected were analyzed using SPSS version 16 and 
statistical correlation of the variables was per-formed 
using Pearson’s Chi-square, with a confidence level of 
95% and probability values (p-value) of P<0.05 re-
garded as significant. 
 
RESULTS  
Of the 1013 diagnosed lesions within the study period, 
there were 137 (13.5%) paediatric orofacial tumours. 
There was male predilection for the lesions (78 males 
to 59 females, ratio of 1.3:1). The mean age was 9 + 
4.3 years, with overall peak age group of 11 to 15 years 
(n=60, 43.8%) and the peak year was 2008 (n=23, 16.8 
%). The mandible (n=44, 32.1%), followed by the 
maxilla (n=42, 30.7%) and orofacial soft tissue (n=19, 
13.9%) were the most common sites. (Table 1) 
 
Most of the lesions were non-odontogenic tumours 
(n=116, 84.7%) and the benign tumours (n=72, 52.6%) 
were slightly more than the malignant tumours (n=65, 
47.4%) [Tables 1, 2, 3 and 4]. Seventy-one (51.8%) 
cases among the 137 paediatric tumours were diag-
nosed within the last 6 years (2005 to 2010) of the 
study, occurring predominantly in males (48 males to 
23 females, ratio= 2:1) and in the jaws (n=47, 34.3%) 
(Table 5).  
 
The malignant tumours (n=23, 16.8%) were slightly 
more than benign tumours (n=20, 14.6%) within the 
last 3 years (2008 to 2010) under review. The benign 
tumours were mostly ameloblastoma (n=15, 10.9%) 
with 6 (4.4%) cases occurring in the last 6 years; fol-
lowed by juvenile ossifying fibroma (n=11, 8.0%) and 
fibrous dysplasia (n=10, 7.3%). While Burkitt’s lym-
phoma (n=38, 27.7%) and diffuse non-Hodgkin’s lym-
phoma (n=13, 9.5%) were the commonest malignant 
lesions. Twenty-five (18.3%) cases of the Burkitt’s 
lymphomas and 7 (5.1%) cases of diffuse non-
Hodgkin’s lymphoma occurred in the last 6 years. (Ta-
ble 6) 
 
There was significant association of the paediatric oro-
facial tumours for males and the jaws (p<0.05), espe-
cially within the last 6 years under review. There was 
significant association of Burkitt’s lymphoma as the 
predominant paediatric orofacial tumour within the last 
6 years under review (p<0.05).  
 
 
Table 1 Age, gender and orofacial site distribution of paediatric orofacial tumours 










0-5 13 20 33 24.1 Male 42 36 78 56.1 
6-10 14 30 44 32.1 Female 30 29 59 43.1 
11-15 45 15 60 43.8      
Total 72 65 137 100 Total  72 65 137 100 
          




 Total %   
Mandible  28  16  44 32.1   
Maxilla   16  26  42 30.7   
Soft Tissue   7  12  19 13.9   
Parotid   3  -  3 2.2   
Gingivae  10  1  11 8.0   
Palate  10  1  4 2.9   
Submandibular   2  1  2 1.5   
Sublingual   2  -  2 1.5   
Mandible-
Maxilla  
 -  7  7 5.1   
Facial/Scalp skin  1  1  1 1.5   









Table 2 Histopathologic types of the paediatric orofa-
cial benign tumours 
Non-odontogenic tumours Frequency % 
Fibrous dysplasia 10 7.3 
Juvenile ossigying Fibroma 11 8.0 
Pyogenic granuloma 5 3.7 
Haemamgionna 4 2.9 
Granular cell tumour 3 2.2 
Peripheral ossifying Fibroma 5 3.7 
Centrl giant cell Granuloma 3 2.2 
Teratoma 1 0.7 
Lipoma 1 0.7 
Adenolmphoma 1 1.5 
Pleomorphic adenoma 2 0.7 
Melanocytic neuroectodemal 1 2.2 
Periapical granuloma 3 0.7 
Fibroepithelial polyp 1 0.7 
Sub-total 51 37.2 
Odontogenic tumours Frequency % 
Ameloblastoma 15 11.0 
Odontongenic fibromyxoma 2 1.5 
Odontome 1 0.7 
Ameloblastic fibroma 1 0.7 




Sub-total 21 15.3 
TOTAL 72 52.5 
 
 
Table 3 Histopathologic types of the paediatric orofa-
cial malignant tumours 
Malignant Tumour Frequency % 
Burkitt’s lymphoma 38 27.7 
Embryonic rhabdomyosarcoma 4 2.9 
Non-Hodgkin lymphoma 13 9.5 
Squamous cell carcinoma 2 1.5 
Giant cell tumour 1 0.7 
Mucoepidermoid carcinoma 2 1.5 
Neuroblastoma 1 0.7 
Chondrasarcoma 1 0.7 




Total 65 45.5 
 
 
Table 4 Distribution of the benign and malignant pae-








20 11 31 22.6 
1995 to 
1999 
6 6 12 8.8 
2000 
to2004 
11 12 23 16.8 
2005 to 
2010 
35 36 71 51.8 
Total 72 65 137 100 
 
 
Table 5 Gender and orofacial sites distribution of paediatric orofacial tumour from 2005 to 2010 
GENDER YEAR 
 2005 2006 2007 2008 2009 2010 Total  % 
Male  10 5 6 13 6 8 48 35.0 
Female 3 2 2 10 3 3 23 16.8 
Total 13 7 8 23 9 11 71 51.8 
Orofacial Sites         
Mandible 7 1 1 5 5 5 24 17.5 
Maxilla 5 1 2 12 1 2 23 16.8 
Soft Tissue - 1 2 - 2 1 6 4.4 
Gingivae - 1 1 3 - 1 6 4.4 
Palate 1 - 1 - - 1 3 2.2 
Submandibular - - - 1 - - 1 0.7 
Mandible-Maxilla - 2 1 2 - 1 6 4.4 
Facial/scalp skin - 1 - - 1 - 2 1.4 
















Benign Tumours 2005 2006 2007 2008 2009 2010 total 
Ameloblastoma 1 - - 2 3 - 6 
Odontogenic fibromyxoma 1 - - - - - 1 
Odontome 1 - 1 - - - 2 
Peripheral odontogenic fi-
broma 
- 1 - - - - 1 
Fibrous dysplasia - - - 2 1 1 4 
Juvenile ossigying fibroma - - 1 - - 1 2 
Pyogenic granuloma - - - - - 1 1 
Haemangioma - 1 - - 1 - 2 
Granular cell tumour 2 - - - - - 2 
Peripheral ossifying fibroma - 1 1 2 - - 4 
Central giant cell granuloma - - 1 2 2 - 5 
Lipoma - - - 1 - - 1 
Periapical granuloma 3 - - - - - 3 
Fibroepithelial - - - - - 1 1 
Malignant tumours        
Burkitt’s lymphoma 4 4 3 12 1 1 25 
Non-hodgkin lymphoma 1 - - 1 - 5 7 
Squamous cell carcinoma - - - 1 - - 1 
Chondrosarcoma - - 1 - - - 1 
Malignant fibrous histocyto-
ma 
- - - - 1 - 1 
Polymorphous low grade 
adenocarcinoma 
- - - - - 1 1 
Total 13 7 8 23 9 11 71 
Percentage 9.5 5.1 5.8 16.8 6.6 8.0 51.8 
 
DISCUSSION 
Several reports1-3,16 between year 1996 and 2000 
showed a relatively low incidence of paediatric 
orofacial tumours, which suggests that the lesions 
did not constitute great risk to oral health of chil-
dren about a decade ago, compared to dental caries 
that was regard- 
 
ed as the highest oral health concern among paedi-
atric patients.17 Recent studies among black Afri-
can population shows an increasing incidence of 
malignant paediatric orofacial tumours, and has 
apparently raised oral health concerns for these 
population.18 This study was carried out among a 
population in the South-South zone of Nigeria and 
a similar pattern of increased incidence (13.5%) of 
paediatric orofacial tumours though relatively, with 
predilection for males and the jaws, and peak age 
range of 11 to 15 years was observed, especially 





This study showed a predominant non-odontogenic paedi-
atric orofacial tumour, with a narrowing of the gap be-
tween the incidence of benign tumours (52.6%) and malig-
nant tumours (47.4%). Furthermore, a slight-ly higher inci-
dence of malignant tumours (16.8%), compared to benign 
tumours (14.6%) was observed in the last 3 years (2008 to 
2010) of the study. Burkitt lymphoma accounted mainly 
for the increase incidence of paediatric orofacial tumour 
observed within the last 6 years of the study, with a peak 
inci-dence in 2008.  
 
Although a reduction in Burkitt lymphoma was observed in 
the last 2 years (2009 and 2010) of the study, the increase 
incidence of paediatric orofacial tumour in 2009 and 2010 
were mainly due to ameloblastoma and diffuse non-
Hodgkin lymphoma respectively. This study agrees with 
the recent report of a higher incidence of malignant paedi-
atric orofacial tumours in our environment by Aregbesola 
et al.5 On the contrary, a recent African study by Elarbi et 
al, reported a lower incidence of malignant paediatric oro-
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Therefore, the in-creasing incidence of malignant 
paediatric orofacial tumours and the attendant in-
crease in oral health concerns appears not to be 
wide spread in Africa, but more pronounced in our 
environment.    
 
The histopathologic pattern of the paediatric orofa-
cial tumours studied showed that Burkitt’s lym-
phoma was the commonest malignant lesion, while 
ameloblastoma was the commonest benign tumour. 
These tumours also accounted for most of the le-
sions within the 6-year surge period for paediatric 
orofacial tumours observed in this study. Similarly, 
previous studies 4-6, 16 in our environment reported 
that Burkitt’s lymphoma was the predominant ma-
lignant paediatric orofacial tumour.   
 
It appears that the increase in oral health concerns 
for paediatric orofacial tumour in our environment 
may be primarily due to increase in the incidence 
of Burkitt’s lymphoma. The reasons for this finding 
may not be unconnected with the poor control of 
infections by Epstein Barr virus (EBV) and plas-
modium falciparum (malaria parasite), which are 
the two infections strongly associated with the 
pathogenesis of Burkitt’s lymphoma. 19,20 However, 
it was reported that funding to control malaria in 
sub-Saharan Africa has increased between 1999 
and 2004.21 Apart from controlling repeated attacks 
of malaria, the molecular genetics of Burkitt’s 
lymphoma need to be revisited. This is because the 
known sites of chromosomal translocation may not 
be the only sites where mutations in the B-
lymphocytes now occur. Furthermore, there are 
reports suggesting that variation in the pattern of 
chromosomal mutation in endemic and sporadic 
Burkitt’s lymphoma 22, as well as the rapid accu-
mulation of p53 protein in both EBV positive and 
negative B-lymphocytes 23, 24 may be the other fac-
tors involved the development of Burkitt’s lym-
phoma.  
 
In our environment, other possible factors that may 
have contributed to increase in the incidence of 
paediatric orofacial tumours include; increase pub-
lic awareness about oral health care and the estab-
lishment of more oral health care centres, with 
more specialist diagnosticians and improved diag-
nostic facilities for orofacial disease.  
 
In conclusion, this study showed a recent increase 
in the incidence of paediatric orofacial tumours 
particu-larly in the jaws and among males, due to a 
higher incidence of Burkitt’s lymphomas among 
other possible factors recognized in our environ-
ment. However, larger prospective studies are re-
quired to determine if the finding in our Centre is applica-
ble to the general paedi-atric population. This study sug-
gests a higher oral health concerns for Burkitt’s lymphoma 
among paedi-atric patients. We therefore recommend a 
more efficient utilization of the available funds for control 
of malaria infection, to help reduce the rapid rate of de-
velopment of Burkitt’s lymphoma in our environment.  
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